Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
+1,577
New +$185K 0.03% 159
2025
Q1
Sell
-3,163
Closed -$315K 190
2024
Q4
$315K Buy
3,163
+295
+10% +$30.4K 0.05% 165
2024
Q3
$326K Buy
2,868
+297
+12% +$35.3K 0.05% 161
2024
Q2
$318K Buy
2,571
+89
+4% +$11.5K 0.05% 158
2024
Q1
$328K Hold
2,482
0.06% 155
2023
Q4
$294K Sell
2,482
-56
-2% -$5.81K 0.06% 155
2023
Q3
$261K Buy
2,538
+56
+2% +$6.04K 0.06% 152
2023
Q2
$286K Hold
2,482
0.06% 149
2023
Q1
$264K Sell
2,482
-99
-4% -$10.7K 0.06% 151
2022
Q4
$286K Buy
2,581
+4
+0.2% +$409 0.07% 151
2022
Q3
$222K Buy
2,577
+231
+10% +$20.6K 0.06% 153
2022
Q2
$214K Buy
+2,346
New +$208K 0.05% 158

Other funds holding MRK

ERn Financial LLC's MRK Position: Q2 2026 in Review

ERn Financial LLC opened a new position in Merck (MRK) in Q2 2026: 1,577 shares worth $203K. The stake represents 0.03% of the portfolio and ranks #159 among its holdings. This is a return to the name: ERn Financial LLC previously reported a position in MRK as recently as Q4 2024.

ERn Financial LLC first reported a position in MRK in Q2 2022 and has held it in 12 quarters since. The position peaked at $328K in Q1 2024. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ERn Financial LLC held 1,577 shares of Merck worth $203K as of Q2 2026.
  • Merck was a new ERn Financial LLC position in Q2 2026.
  • Merck made up 0.03% of ERn Financial LLC's portfolio in Q2 2026, its #159 holding.
  • ERn Financial LLC first reported a position in Merck in Q2 2022 and has held it in 12 quarters since.
  • ERn Financial LLC's Merck position peaked at $328K in Q1 2024.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ERn Financial LLC's 13F filing for Q2 2026, filed 23 Jul 2026.